Loading...
FFS: an end(point) to our problems in chronic GVHD trials?
In this issue of Blood, Inamoto et al provide encouragement that we are reaching the time where we have a robust endpoint to use in large, randomized clinical trials testing novel agents in chronic graft-versus-host disease (GVHD).(1)
Saved in:
| Main Author: | |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society of Hematology
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4141511/ https://ncbi.nlm.nih.gov/pubmed/25147381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-06-579672 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|